Dementia News and Research

Latest Dementia News and Research

Study may spur research into multi-model imaging based biomarker development for AD

Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.

31 Aug 2012

Closing in on neurologic biomarker diagnosis

A panel of five cerebrospinal fluid biomarkers may help doctors to accurately diagnose patients with various forms of dementia and parkinsonian disorders, research published in the Archives of Neurology suggests.

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

Elevated CRP is phenotype for familial preserved cognition

The first-degree relatives of very old people with preserved cognition and elevated C-reactive protein have a low risk for developing dementia, research shows.

29 Aug 2012

Researchers discover new genetic disease related to vitamin B12 deficiency

Vitamin B12 is essential to human health. However, some people have inherited conditions that leave them unable to process vitamin B12. As a result they are prone to serious health problems, including developmental delay, psychosis, stroke and dementia. An international research team recently discovered a new genetic disease related to vitamin B12 deficiency by identifying a gene that is vital to the transport of vitamin into the cells of the body.

27 Aug 2012

Lilly’s solanezumab Phase 3 trials on AD do not meet primary endpoints

Eli Lilly and Company today announced that the primary endpoints, both cognitive and functional, were not met in either of the two Phase 3, double-blind, placebo-controlled solanezumab EXPEDITION trials in patients with mild-to-moderate Alzheimer's disease.

24 Aug 2012

Women with Alzheimer's show worse mental deterioration than men

Women with Alzheimer's show worse mental deterioration than men with the disease, even when at the same stage of the condition, according to researchers from the University of Hertfordshire.

24 Aug 2012

Nonoperative management of inflamed gallbladder may be best for elderly

Medical rather than surgical management of acute cholecystitis – or inflamed gallbladder – may be the most appropriate option for elderly patients who may be unsuitable for surgery, report researchers.

23 Aug 2012

Study might help solve the biggest mystery of Parkinson’s

The recent discoveries that α-Synuclein(α-Syn) protein, a central player in Parkinson´s disease (PD) brain destruction, could not only pass from one neuron to another but also exist outside neuronal cells has led to major rethink on the disease.

23 Aug 2012

Simple eye tracking test could hold key to early Alzheimer's diagnosis

A simple eye tracking test could hold the key to earlier Alzheimer's diagnosis, according to new research published today in the Journal of the American Aging Association.

23 Aug 2012

Working memory capacity in patients with Parkinson's can be improved with sleep

People with Parkinson's disease performed markedly better on a test of working memory after a night's sleep, and sleep disorders can interfere with that benefit, researchers have shown.

22 Aug 2012

Parkinson’s disease with dementia falls into two pathologic subgroups

Patients with Parkinson’s disease who also have dementia fall into two main pathologic categories, characterized by neocortical synucleinopathy in isolation and neocortical synucleinopathy with amyloid beta deposition.

20 Aug 2012

People with no dementia symptoms and high protein levels more likely to avoid the disease

People who are free of dementia and have high levels of a protein that indicates the presence of inflammation have relatives who are more likely to avoid the disease as well, according to a new study published in the August 15, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Aug 2012

Book provides up-to-date knowledge about mild cognitive impairment

At least one in ten adults over the age of 65 suffers from Mild Cognitive Impairment, or MCI. This condition, a state between the normal decline in cognition associated with aging and the more precipitous drop caused by a deadly dementia like Alzheimer's disease, has only recently begun to be studied; first identified by the Mayo Clinic in 1999, it was only given an official diagnostic code in late 2006.

16 Aug 2012

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

14 Aug 2012

Health law critically important to women; Expanding Medicaid could spur state education cuts; Misuse of antipsychotics in dementia patients

If we can set aside the political wrangling and focus on the benefits of the Affordable Care Act, what becomes obvious is its critically important impact on women's health. The fact is while women are the primary coordinators of health care for families and comprise the majority of U.S. health-care workers, they also put their own health-care needs behind those of their children. Cost is too often the reason.

13 Aug 2012

Latrepirdine demonstrates new potential against neurodegenerative conditions

The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.

13 Aug 2012

Migraines not associated with cognitive decline

Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease. Previous studies have linked this disorder to an increased risk of stroke and structural brain lesions, but it has remained unclear whether migraines had other negative consequences such as dementia or cognitive decline.

12 Aug 2012

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

8 Aug 2012

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

7 Aug 2012

Dementia News and Research

Latest Dementia News and Research

Study may spur research into multi-model imaging based biomarker development for AD

Closing in on neurologic biomarker diagnosis

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Elevated CRP is phenotype for familial preserved cognition

Researchers discover new genetic disease related to vitamin B12 deficiency

Lilly’s solanezumab Phase 3 trials on AD do not meet primary endpoints

Women with Alzheimer's show worse mental deterioration than men

Nonoperative management of inflamed gallbladder may be best for elderly

Study might help solve the biggest mystery of Parkinson’s

Simple eye tracking test could hold key to early Alzheimer's diagnosis

Working memory capacity in patients with Parkinson's can be improved with sleep

Parkinson’s disease with dementia falls into two pathologic subgroups

People with no dementia symptoms and high protein levels more likely to avoid the disease

Book provides up-to-date knowledge about mild cognitive impairment

Latrepiridine reduces level of at least two neurodegeneration-related proteins in mice

Health law critically important to women; Expanding Medicaid could spur state education cuts; Misuse of antipsychotics in dementia patients

Latrepirdine demonstrates new potential against neurodegenerative conditions

Migraines not associated with cognitive decline

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Dementia News and Research

Latest Dementia News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in